Breaking News Instant updates and real-time market news.

MYL

Mylan

$40.37

1.14 (2.91%)

11:00
05/17/18
05/17
11:00
05/17/18
11:00

Massive spread in Mylan

Massive spread in Mylan. The stock up $1.08 to $40.26 and 52.6K Jun 40 - 42.5 call spreads sold at 95c. The Jun 42.5 calls are opening and the other leg likely closes a matching block opened for 53c on 5/3 with MYL at $35.74. The option block is being rolled up 2.5 strikes after the 12.6% rally in the underlying. Earnings reported 5/9.

  • 18

    May

  • 13

    Nov

MYL Mylan
$40.37

1.14 (2.91%)

04/19/18
WELS
04/19/18
NO CHANGE
WELS
Wells says bottom has not been reached in generics pricing
After Aceto (ACET) cited the continued intense competitive and pricing pressures in the generic industry when withdrawing its guidance last night, and Novartis (NVS) this morning reported that net sales at its generic unit Sandoz dropped 4% in the quarter, Wells Fargo analyst Davis Maris says he's not ready to call the bottom in generics pricing. Those that have are premature, Maris tells investors in a research note titled "Negative Read Throughs For Generics Continue." The Aceto and Sandoz pricing news shows the data continue to be negative for U.S. generic industry pricing, the analyst contends. He sees a negative read-through for companies with large U.S. commodity generic exposure, such as Teva (TEVA) and Mylan (MYL).
04/23/18
WELS
04/23/18
NO CHANGE
WELS
Market Perform
Mylan layoffs will led to questions, says Wells Fargo
Wells Fargo analyst David Maris acknowledges press reports that Mylan is laying off approximately 500 employees, or approximately 15% of its employees in Morgantown, Virginia. Investors will have questions when Mylan reports Q1 results about the layoffs and what Mylan means about the need to make the Morgantown plant less complex, Maris tells investors in a research note. He keeps a Market Perform on Mylan shares.
04/25/18
WELS
04/25/18
NO CHANGE
WELS
Market Perform
Glaxo comments on Advair have negative read through for Mylan, says Wells Fargo
Noting that GlaxoSmithKline (GSK) said it now expects branded Advair sales to decline 30% this year, even excluding the impact of a generic, Wells Fargo analyst David Maris said the news has a negative read through for Mylan (MYL) given that its generic Advair is one of the company's highest profile pipeline items. While Advair will be a good generic opportunity, it represents "a fraction of what some might have previously believed," said Maris, who has a Market Perform rating on Mylan shares.
05/15/18
MZHO
05/15/18
UPGRADE
Target $27
MZHO
Buy
Mizuho compares Valeant portfolio to Mylan in upgrade to Buy
Mizuho analyst Irina Koffler upgraded Valeant Pharmaceuticals (VRX) to Buy from Neutral and raised her price target for the shares to $27 from $15. The stock closed yesterday down 4c to $20.81. Adjusting individual product growth estimates has made the analyst more constructive on Valeant's turnaround story. The company's portfolio now looks Mylan-like (MYL) in that 70% of revenue consists of stable products that are either consumer-focused, or older drugs that are already generic, Koffler tells investors in a research note. Further, the analyst sees growth potential from Valeant's pipeline, which she notes contains multiple catalysts in 2018-2020 and is not in her estimates. She thinks that in order for the stock to work over the next year, Valeant just needs to execute on its quarters and push through new product launches.

TODAY'S FREE FLY STORIES

WBC

Wabco

$114.86

-0.6 (-0.52%)

, BIDU

Baidu

$216.99

-0.58 (-0.27%)

06:34
09/19/18
09/19
06:34
09/19/18
06:34
Hot Stocks
Wabco and Baidu to collaborate on commercial vehicle autonomous driving »

Wabco (WBC) signed a…

WBC

Wabco

$114.86

-0.6 (-0.52%)

BIDU

Baidu

$216.99

-0.58 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 18

    Oct

  • 06

    Nov

NVCR

Novocure

$49.00

2.625 (5.66%)

06:34
09/19/18
09/19
06:34
09/19/18
06:34
Recommendations
Novocure analyst commentary  »

Novocure price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBRL

Cracker Barrel

$143.77

-6.93 (-4.60%)

06:30
09/19/18
09/19
06:30
09/19/18
06:30
Recommendations
Cracker Barrel analyst commentary  »

Cracker Barrel needs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BABA

Alibaba

$156.64

-2.12 (-1.34%)

06:30
09/19/18
09/19
06:30
09/19/18
06:30
Periodicals
China's Alibaba to set up dedicated chip subsidiary, Reuters reports »

Alibaba is planning to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

ABUS

Arbutus Biopharma

$9.55

0.25 (2.69%)

06:30
09/19/18
09/19
06:30
09/19/18
06:30
Conference/Events
Arbutus Biopharma management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

BABA

Alibaba

$156.64

-2.12 (-1.34%)

06:26
09/19/18
09/19
06:26
09/19/18
06:26
Recommendations
Alibaba analyst commentary  »

Alibaba Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

ARPO

Aerpio Pharmaceuticals

$3.77

0.155 (4.29%)

06:26
09/19/18
09/19
06:26
09/19/18
06:26
Initiation
Aerpio Pharmaceuticals initiated  »

Aerpio Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

BK

BNY Mellon

$51.45

0.23 (0.45%)

06:26
09/19/18
09/19
06:26
09/19/18
06:26
Hot Stocks
KPMG admits misconduct on BNY Mellon reports, says watchdog »

The Financial Reporting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 18

    Oct

RNSDF

Renault

$0.00

(0.00%)

, VLKAY

Volkswagen

$0.00

(0.00%)

06:25
09/19/18
09/19
06:25
09/19/18
06:25
Periodicals
Renault, VW, Fiat Chrysler sales surged before new emissions test, Reuters says »

Renault (RNSDF),…

RNSDF

Renault

$0.00

(0.00%)

VLKAY

Volkswagen

$0.00

(0.00%)

FCAU

Fiat Chrysler

$17.62

0.17 (0.97%)

NSANY

Nissan

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGX

Argenx

$87.33

-6.44 (-6.87%)

06:23
09/19/18
09/19
06:23
09/19/18
06:23
Syndicate
Argenx 3.48M share Secondary priced at $86.50 »

Morgan Stanley, Cowen and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 19

    Sep

NFLX

Netflix

$367.85

17.61 (5.03%)

06:23
09/19/18
09/19
06:23
09/19/18
06:23
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 16

    Oct

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

06:23
09/19/18
09/19
06:23
09/19/18
06:23
Hot Stocks
NY Attorney General: Cryptocurrency exchanges lack integrity, security, fairness »

New York Attorney General…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REVB

Revere Bank

$0.00

(0.00%)

06:20
09/19/18
09/19
06:20
09/19/18
06:20
Syndicate
Revere Bank 1.4M share Secondary priced at $29.25 »

Sandler ONeill acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

GTHX

G1 Therapeutics

$62.94

-3.41 (-5.14%)

06:20
09/19/18
09/19
06:20
09/19/18
06:20
Syndicate
G1 Therapeutics 3M share Secondary priced at $60.00 »

JPMorgan and Cowen acted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 19

    Sep

NVS

Novartis

$85.03

-0.1 (-0.12%)

06:18
09/19/18
09/19
06:18
09/19/18
06:18
Hot Stocks
Novartis' Kymriah for adult lymphoma 'to expensive to recommend,' says NICE »

The U.K.'s National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

CNC

Centene

$142.82

1.055 (0.74%)

06:17
09/19/18
09/19
06:17
09/19/18
06:17
Initiation
Centene initiated  »

Centene initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

  • 23

    Oct

  • 14

    Dec

GM

General Motors

$35.11

0.09 (0.26%)

, TSLA

Tesla

$284.88

-9.9 (-3.36%)

06:17
09/19/18
09/19
06:17
09/19/18
06:17
Periodicals
Former GM exec Lutz says Tesla is 'headed for the graveyard', CNBC reports »

Bob Lutz, former vice…

GM

General Motors

$35.11

0.09 (0.26%)

TSLA

Tesla

$284.88

-9.9 (-3.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 29

    Oct

AAPL

Apple

06:14
09/19/18
09/19
06:14
09/19/18
06:14
Recommendations
Apple analyst commentary  »

Apple offers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCEHY

Tencent

$0.00

(0.00%)

, IQ

iQIYI

$26.29

-0.54 (-2.01%)

06:14
09/19/18
09/19
06:14
09/19/18
06:14
Periodicals
Tencent Music cuts size of U.S. IPO to $2B, Reuters reports »

Chinese music-streaming…

TCEHY

Tencent

$0.00

(0.00%)

IQ

iQIYI

$26.29

-0.54 (-2.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIG

Transocean

$11.93

0.335 (2.89%)

, RDC

Rowan Companies

$16.25

0.56 (3.57%)

06:13
09/19/18
09/19
06:13
09/19/18
06:13
Upgrade
Transocean, Rowan Companies, Ensco, Noble Corp. rating change  »

Transocean upgraded to…

RIG

Transocean

$11.93

0.335 (2.89%)

RDC

Rowan Companies

$16.25

0.56 (3.57%)

ESV

Ensco

$7.40

0.28 (3.93%)

NE

Noble Corp.

$6.15

0.19 (3.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

SIR

Select Income REIT

$20.53

-1.18 (-5.44%)

06:13
09/19/18
09/19
06:13
09/19/18
06:13
Upgrade
Select Income REIT rating change  »

Select Income REIT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RFP

Resolute Forest

$14.65

0.125 (0.86%)

06:12
09/19/18
09/19
06:12
09/19/18
06:12
Downgrade
Resolute Forest rating change  »

Resolute Forest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$109.55

0.18 (0.16%)

06:11
09/19/18
09/19
06:11
09/19/18
06:11
Periodicals
Marvel heroes to get own TV series on Disney streaming service, Variety reports »

Disney is in early…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

MCD

McDonald's

$157.77

-0.38 (-0.24%)

06:10
09/19/18
09/19
06:10
09/19/18
06:10
Hot Stocks
EU says McDonald's, Luxembourg tax deal not illegal »

The European Commission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ETFC

E-Trade

$53.77

0.46 (0.86%)

06:08
09/19/18
09/19
06:08
09/19/18
06:08
Upgrade
E-Trade rating change  »

E-Trade upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.